Table 6.6d

Immunosuppression Use for Maintenance by Regimen

Prior to Discharge, 1995 to 2004

Recipients with Pancreas Transplant Alone (PTA) Transplants

  Transplant Year
1995 1996 1997 1998 1999 2000 2001 2002 2003 2004
Functioning Graft at Discharge 37 44 67 73 125 114 149 164 143 172
With Immunosuppression Info 36 42 66 66 123 112 142 151 117 159
--- + MMF/MPA 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 13.7% 20.8%
--- + MMF/MPA + Siro/Evero 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.9% 0.0%
--- + MMF/MPA + Steroids 0.0% 0.0% 4.5% 4.5% 2.4% 0.0% 0.0% 0.0% 0.0% 0.6%
--- + OtherAntimet 5.6% 2.4% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
--- + OtherAntimet + Steroids 0.0% 2.4% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
--- + Siro/Evero 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.7% 0.9% 0.6%
--- + Siro/Evero + Steroids 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.7% 0.0% 0.9% 0.6%
--- + Steroids 0.0% 0.0% 3.0% 0.0% 0.0% 0.9% 0.0% 0.7% 0.9% 1.9%
CyA + MMF/MPA 2.8% 0.0% 1.5% 1.5% 0.0% 0.0% 0.7% 1.3% 0.9% 0.6%
CyA + MMF/MPA + Steroids 2.8% 7.1% 6.1% 1.5% 2.4% 3.6% 3.5% 1.3% 0.9% 0.0%
CyA + OtherAntimet 19.4% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
CyA + OtherAntimet + Steroids 0.0% 4.8% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
CyA + Siro/Evero + Steroids 0.0% 0.0% 0.0% 0.0% 0.0% 0.9% 0.0% 0.7% 0.9% 0.6%
CyA + Steroids 8.3% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Tac 8.3% 0.0% 0.0% 1.5% 25.2% 14.3% 14.8% 15.2% 2.6% 10.1%
Tac + MMF/MPA 5.6% 16.7% 3.0% 0.0% 2.4% 0.9% 0.0% 1.3% 6.8% 8.8%
Tac + MMF/MPA + Siro/Evero 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.7% 3.3% 0.0% 1.3%
Tac + MMF/MPA + Steroids 8.3% 54.8% 72.7% 71.2% 56.9% 63.4% 57.0% 55.0% 45.3% 28.9%
Tac + OtherAntimet 30.6% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Tac + OtherAntimet + Steroids 2.8% 2.4% 4.5% 4.5% 0.0% 1.8% 0.7% 0.7% 0.0% 1.3%
Tac + Siro/Evero 0.0% 0.0% 0.0% 0.0% 0.8% 0.0% 2.1% 2.0% 12.8% 7.5%
Tac + Siro/Evero + Steroids 0.0% 0.0% 0.0% 0.0% 0.8% 6.3% 5.6% 7.9% 1.7% 0.6%
Tac + Steroids 0.0% 4.8% 3.0% 9.1% 8.9% 4.5% 12.0% 6.6% 8.5% 15.1%
Other Regimen 5.6% 4.8% 1.5% 6.1% 0.0% 3.6% 2.1% 3.3% 2.6% 0.6%


Source: OPTN/SRTR Data as of May 2, 2005.

Percentages in each column sum to 100 percent.

---: No Calcineurin Inhibitor Use; CyA: Cyclosporine; Tac: Tacrolimus.

MMF: Mycophenolate Mofetil; MPA: Mycophenolate Sodium; Siro: Sirolimus; Evero: Everolimus; OtherAntimet: Antimetabolites excluding MMF and MPA.

"Other Regimen" includes drug combinations that are different from the listed regimens and drugs from the text field entering.